Marc Elia - 22 Jun 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Director, Other*
Signature
/s/ Jill Andersen attorney-in-fact for Marc Elia
Issuer symbol
IVVD
Transactions as of
22 Jun 2022
Transactions value $
$0
Form type
4
Filing time
24 Jun 2022, 16:40:02 UTC
Previous filing
16 Jun 2022
Next filing
19 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +150,000 $0 150,000 22 Jun 2022 Common Stock 150,000 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 22, 2022 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the shares subject to the grant vesting in equal monthly installments thereafter, subject to continued service through each vesting date. The grant was awarded to Marc Elia ("Mr. Elia"). Mr. Elia is deemed to hold the grant for the benefit of M28 Capital Management LP ("M28 Capital Management") and the funds managed by M28 Capital Management.

Remarks:

M28 Capital Management may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Mr. Elia, who indirectly controls M28 Capital Management, currently serves on the board of directors of the Issuer. Exhibit Index: 24.1 Power of Attorney